GlassScriptPhysician profile
Carl L Byrd
NPI 1740662998
$39,868.83
in general payments reported to CMS, 2019-2025
19 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25K · 2021: $8,631 · 2022: $4,023 · 2023: $2,307 · 2024: $233 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,325 · Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,324.58 |
| Food and Beverage | $391.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,253.55 | 2020-2021 | |
| Smith+Nephew, INC. | $7,730.50 | 2020-2025 | Na, Q-Fix |
| Alpha Orthopedic Systems | $3,817.59 | 2021-2022 | |
| Djo, LLC | $3,000.00 | 2020-2021 | |
| Stryker Corporation | $2,606.88 | 2021-2024 | Mako |
| Boston Scientific Corporation | $133.16 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $41.64 | 2021-2024 | Prolia, Evenity |
| Convatec INC. | $39.16 | 2023 | |
| Vericel Corporation | $36.24 | 2022 | |
| Depuy Synthes Sales INC. | $32.53 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.36 | 2023-2025 | Zilretta |
| Medtronic, INC. | $26.69 | 2025 | Minimed 780g |
| Kowa Pharmaceuticals America, INC. | $26.38 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $18.88 | 2023 | |
| Sanara Medtech INC. | $18.01 | 2024 | Celleraterx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $16.25 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.86 | 2023 | Strensiq |
| Radius Health, INC. | $14.97 | 2023 | Tymlos |
| Heron Therapeutics, INC. | $10.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.